Short answer

Embrace iterative technological adoption and process optimization to enhance the speed and breadth of research and development efforts.

Field
Commercial Production
Source
British Journal of Pharmacology (2007)
Method
Historical case study and process analysis
Evidence
Strong effect

The strategic implementation of high-throughput screening (HTS) methodologies, evolving from manual to automated processes, significantly accelerates the identification of potential drug candidates, thereby streamlining the drug discovery pipeline. This commercial production research insight is drawn from a 2007 study published in British Journal of Pharmacology. Using Historical case study and process analysis, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Embrace iterative technological adoption and process optimization to enhance the speed and breadth of research and development efforts.

Study
Commercial ProductionHigh ImpactStrong effect

High-Throughput Screening: A Catalyst for Accelerated Drug Discovery

The strategic implementation of high-throughput screening (HTS) methodologies, evolving from manual to automated processes, significantly accelerates the identification of potential drug candidates, thereby streamlining the drug discovery pipeline.

British Journal of Pharmacology · 2007

01

Key Findings

  • 01HTS evolved from natural products screening to synthetic compound screening using 96-well plates with reduced assay volumes.
  • 02Process efficiency increased from 800 compounds per week to 7200 compounds per week by centralizing and synchronizing screening operations.
  • 03Integration of advanced analytical techniques like autoradiography, image analysis, RT-PCR, and LC-MS expanded the types of targets and assays possible.
  • 04By 1992, HTS contributed starting material for approximately 40% of the discovery portfolio, and by 1999, ADME HTS was fully integrated into the discovery cycle.
02

Application

Design takeaway

Embrace iterative technological adoption and process optimization to enhance the speed and breadth of research and development efforts.

How to apply

Analyze current research or development processes to identify bottlenecks and opportunities for automation, miniaturization, or the integration of advanced analytical tools.

Project actions

  • 01When documenting your design process, clearly show how you improved your methods over time.
  • 02Consider how different technologies could be combined to solve a design problem more efficiently.
03

Method & Evidence

AimHow has the evolution of high-throughput screening methodologies impacted the efficiency and scope of drug discovery within a pharmaceutical company?
MethodHistorical case study and process analysis
ProcedureThe research traces the development of HTS at a specific pharmaceutical company, detailing the adoption of new technologies (e.g., 96-well plates, automated liquid handling, LC-MS, image analysis) and process changes (e.g., centralization, lock-step operation, integration of ADMET targets).
ContextPharmaceutical drug discovery and development

Variables

IVImplementation of HTS technologies and process changes (e.g., automation, miniaturization, centralization).
DVScreening throughput (compounds/week), contribution to discovery portfolio, integration into discovery cycle.
CVOrganizational structure, specific drug targets, regulatory environment (implicitly).
04

Strengths & Limitations

Strengths

  • +Provides a detailed historical account of technological and process evolution.
  • +Quantifies the impact of HTS on discovery portfolio contribution.

Limitations

The specific technologies and scale of operations in this study are highly specialized and may not be directly replicable in a smaller-scale design project.

Reliability & validity

The study's reliability is supported by its detailed historical account and quantitative data. Validity is strong within the context of the specific company but may be limited in generalizability due to its case-study nature.

Think critically

To what extent can the principles of HTS optimization be applied to non-pharmaceutical research and development contexts, and what adaptations would be necessary?

05

Design Principles

"Continuous process improvement through technological integration and automation."

Understanding the evolution of HTS provides valuable insights into optimizing research and development processes. It highlights how technological advancements and process integration can dramatically increase efficiency and reduce the time-to-market for new innovations.

06

What This Means for Your Design

This study shows how a drug company got much faster at finding new medicines by using robots and smaller test tubes, looking at thousands of chemicals each week instead of just a few.

How to use in your project

  • 1.Use this as an example of how iterative development and technological adoption can lead to breakthroughs in research efficiency.
07

Add to My Project

08

Quick Cite

Paragraph starter

The evolution of high-throughput screening (HTS) in drug discovery, as exemplified by the case of Pfizer, demonstrates a powerful model for accelerating research. By transitioning from manual to automated processes, integrating diverse analytical techniques, and centralizing operations, the company significantly increased its screening capacity and efficiency. This iterative improvement, driven by technological adoption and process optimization, allowed for the rapid identification of potential drug candidates, contributing to a substantial portion of the company's discovery portfolio and highlighting the critical role of advanced screening methodologies in modern pharmaceutical research.

09

Source

British Journal of Pharmacology

Origin and evolution of high throughput screening

journal · 2007

View source

Questions About This Research

What does the research say about high-throughput screening: a catalyst for accelerated drug discovery?
Embrace iterative technological adoption and process optimization to enhance the speed and breadth of research and development efforts. Evidence: British Journal of Pharmacology (2007).
Why does "High-Throughput Screening: A Catalyst for Accelerated Drug Discovery" matter for design?
Understanding the evolution of HTS provides valuable insights into optimizing research and development processes. It highlights how technological advancements and process integration can dramatically increase efficiency and reduce the time-to-market for new innovations.
How can designers apply this research?
Embrace iterative technological adoption and process optimization to enhance the speed and breadth of research and development efforts.
What were the main findings?
HTS evolved from natural products screening to synthetic compound screening using 96-well plates with reduced assay volumes.. Process efficiency increased from 800 compounds per week to 7200 compounds per week by centralizing and synchronizing screening operations.. Integration of advanced analytical techniques like autoradiography, image analysis, RT-PCR, and LC-MS expanded the types of targets and assays possible.. By 1992, HTS contributed starting material for approximately 40% of the discovery portfolio, and by 1999, ADME HTS was fully integrated into the discovery cycle.
What research method was used?
Historical case study and process analysis.
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2007 journal from British Journal of Pharmacology.
What should I do differently in my next project?
Analyze current research or development processes to identify bottlenecks and opportunities for automation, miniaturization, or the integration of advanced analytical tools.
What are the limitations?
The findings are specific to the experience of a single pharmaceutical company and may not be universally applicable without considering organizational context and resource availability.